SMAD‑6, ‑7 and ‑9 are potential molecular biomarkers for the prognosis in human lung cancer
- Authors:
- Shuxian Pan
- Guangming Zhou
- Wentao Hu
- Hailong Pei
-
Affiliations: State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, Jiangsu 215123, P.R. China - Published online on: July 9, 2020 https://doi.org/10.3892/ol.2020.11851
- Pages: 2633-2644
-
Copyright: © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Weller DP, Peake MD and Field JK: Presentation of lung cancer in primary care. NPJ Prim Care Respir Med. 29:212019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Y, Wang W, Liang H, Yang CJ, D'Amico T, Ng CSH, Liu CC, Petersen RH, Rocco G, Brunelli A, et al: The optimal treatment for stage IIIA-N2 non-small cell lung cancer: A network meta-analysis. Ann Thorac Surg. 107:1866–1875. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Budi EH, Duan D and Derynck R: Transforming growth factor-β receptors and smads: Regulatory complexity and functional versatility. Trends Cell Biol. 27:658–672. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Luo K: signaling cross talk between TGF-β/Smad and other signaling pathways. Cold Spring Harb Perspect Biol. 9:a0221372017. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y and Feng XH: TGF-β signaling in cell fate control and cancer. Curr Opin Cell Biol. 61:56–63. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kamato D, Do BH, Osman N, Ross BP, Mohamed R, Xu S and Little PJ: Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling. Cell Mol Life Sci. 77:243–251. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Silvestri L, Nai A, Dulja A and Pagani A: Hepcidin and the BMP-SMAD pathway: An unexpected liaison. Vitam Horm. 110:71–99. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dai J, Xu M, Zhang X, Niu Q, Hu Y, Li Y and Li S: Bi-directional regulation of TGF-β/Smad pathway by arsenic: A systemic review and meta-analysis of in vivo and in vitro studies. Life Sci. 220:92–105. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Eckhardt BL, Cao Y, Redfern AD, Chi LH, Burrows AD, Roslan S, Sloan EK, Parker BS, Loi S, Ueno NT, et al: Activation of canonical BMP4-SMAD7 signaling suppresses breast cancer metastasis. Cancer Res. 80:1304–1315. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lang C, Dai Y, Wu Z, Yang Q, He S, Zhang X, Guo W, Lai Y, Du H, Wang H, et al: SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis. Mol Oncol. 14:808–828. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Zeng Y, Liu T, Du W, Zhu J, Liu Z and Huang JA: The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer. Respir Res. 20:1642019. View Article : Google Scholar : PubMed/NCBI | |
|
Tuncer E, Calcada RR, Zingg D, Varum S, Cheng P, Freiberger SN, Deng CX, Kleiter I, Levesque MP, Dummer R and Sommer L: SMAD signaling promotes melanoma metastasis independently of phenotype switching. J Clin Invest. 129:2702–2716. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Jung M, Lee JH, Lee C, Park JH, Park YR and Moon KC: Prognostic implication of pAMPK immunohistochemical staining by subcellular location and its association with SMAD protein expression in clear cell renal cell carcinoma. Cancers (Basel). 11:16022019. View Article : Google Scholar | |
|
Leng Z, Li Y, Zhou G, Lv X, Ai W, Li J and Hou L: Krüppel-like factor 4 regulates stemness and mesenchymal properties of colorectal cancer stem cells through the TGF-β1/Smad/snail pathway. J Cell Mol Med. 24:1866–1877. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Bai Y, Li LD, Li J, Chen RF, Yu HL, Sun HF, Wang JY and Lu X: A FXYD5/TGF-β/SMAD positive feedback loop drives epithelial-to-mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer. Int J Oncol. 56:301–314. 2020.PubMed/NCBI | |
|
Chen J, Deng Y, Ao L, Song Y, Xu Y, Wang CC, Choy KW, Tony Chung KH, Du Q, Sui Y, et al: The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer. Cancer Lett. 460:75–85. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu CW, Li CH, Peng YJ, Cheng YW, Chen HW, Liao PL, Kang JJ and Yeng MH: Snail regulates Nanog status during the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer. Oncotarget. 5:3880–3894. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yang D, Ma M, Zhou W, Yang B and Xiao C: Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells. Chemosphere. 184:289–298. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tang YN, Ding WQ, Guo XJ, Yuan XW, Wang DM and Song JG: Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis. Nat Commun. 6:82302015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Xiao M, Gu S, Xu Y, Liu T, Li H, Yu Y, Qin L, Zhu Y, Chen F, et al: ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions. Nat Cell Biol. 21:179–189. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Rao G, Pierobon M, Kim IK, Hsu WH, Deng J, Moon YW, Petricoin EF, Zhang YW, Wang Y and Giaccone G: Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations. Sci Rep. 7:70662017. View Article : Google Scholar : PubMed/NCBI | |
|
Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, Segura MF, Zhang X and Hu G: MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun. 7:138842016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Ouyang S, Zhou Z, Wang M, Wang T, Qi Y, Zhao C, Chen K and Dai L: Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from oncomine and the cancer genome atlas databases. Mol Genet Genomic Med. 7:e005282019.PubMed/NCBI | |
|
Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 8:816–824. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, et al: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA. 98:13784–13789. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Yamagata N, Shyr Y, Yanagisawa K, Edgerton M, Dang TP, Gonzalez A, Nadaf S, Larsen P, Roberts JR, Nesbitt JC, et al: A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res. 9:4695–4704. 2003.PubMed/NCBI | |
|
Pei YF, Xu XN, Wang ZF, Wang FW, Wu WD, Geng JF and Liu XQ: Methyl-CpG binding domain protein 2 inhibits the malignant characteristic of lung adenocarcinoma through the epigenetic modulation of 10 to 11 translocation 1 and miR-200s. Am J Pathol. 189:1065–1076. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Loraine AE, Blakley IC, Jagadeesan S, Harper J, Miller G and Firon N: Analysis and visualization of RNA-Seq expression data using RStudio, bioconductor, and integrated genome browser. Methods Mol Biol. 1284:481–501. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Benso A, Di Carlo S, Politano G, Savino A and Hafeezurrehman H: Building gene expression profile classifiers with a simple and efficient rejection option in R. BMC Bioinformatics. 12 (Suppl 13):S32011. View Article : Google Scholar : PubMed/NCBI | |
|
Leek JT, Johnson WE, Parker HS, Jaffe AE and Storey JD: The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 28:882–883. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45 (W1). W98–W102. 2017. View Article : Google Scholar | |
|
Israel Y, Rachmiel A, Gourevich K and Nagler R: Kaplan-Meier analysis of salivary gland tumors: Prognosis and long-term survival. J Cancer Res Clin Oncol. 145:2123–2130. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kim J: Drawing guideline for JKMS manuscript (01) Kaplan-Meier curve and survival analysis. J Korean Med Sci. 34:e352019. View Article : Google Scholar : PubMed/NCBI | |
|
Sun CC, Zhou Q, Hu W, Li SJ, Zhang F, Chen ZL, Li G, Bi ZY, Bi YY, Gong FY, et al: Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma. Aging (Albany NY). 10:973–987. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Unberath P, Knell C, Prokosch HU and Christoph J: Developing new analysis functions for a translational research platform: Extending the cBioPortal for cancer genomics. Stud Health Technol Inform. 258:46–50. 2019.PubMed/NCBI | |
|
Tarca AL, Romero R, Erez O, Gudicha DW, Than NG, Benshalom-Tirosh N, Pacora P, Hsu CD, Chaiworapongsa T, Hassan SS and Gomez-Lopez N: Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: A longitudinal study. J Matern Fetal Neonatal Med. 1–12. 2020.(Online ahead of print). View Article : Google Scholar | |
|
Li B and Dewey CN: RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 12:3232011. View Article : Google Scholar : PubMed/NCBI | |
|
Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al: Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res. 22:1197–1211. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA. 98:13790–13795. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S, et al: Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rami-Porta R, Asamura H, Travis WD and Rusch VW: Lung cancer-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 67:138–155. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gurrapu S, Franzolin G, Fard D, Accardo M, Medico E, Sarotto I, Sapino A, Isella C and Tamagnone L: Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells. Sci Signal. 12:eaav20412019. View Article : Google Scholar : PubMed/NCBI | |
|
Girolami I, Veronese N, Smith L, Caruso MG, Reddavide R, Leandro G, Demurtas J and Nottegar A: The activation status of the TGF-β transducer Smad2 is associated with a reduced survival in gastrointestinal cancers: A systematic review and meta-analysis. Int J Mol Sci. 20:38312019. View Article : Google Scholar | |
|
Liang C, Xu J, Meng Q, Zhang B, Liu J, Hua J, Zhang Y, Shi S and Yu X: TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status. Autophagy. 16:486–500. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jeon HS, Dracheva T, Yang SH, Meerzaman D, Fukuoka J, Shakoori A, Shilo K, Travis WD and Jen J: SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells. Cancer Res. 68:9686–9692. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ma L, Jiang H, Xu X, Zhang C, Niu Y, Wang Z, Tao Y, Li Y, Cai F, Zhang X, et al: Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway. Aging (Albany NY). 11:9719–9737. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Karmokar PF, Asaduzzaman M, Islam MS, Shahriar M and Shabnaz S: The influence of SMAD1 gene polymorphisms on colorectal cancer susceptibility in Bangladeshi population: A case-control study. FEBS Open Bio. 8:3402018. | |
|
Cheng M, Jiang Y, Yang H, Zhao D, Li L and Liu X: FLNA promotes chemoresistance of colorectal cancer through inducing epithelial-mesenchymal transition and smad2 signaling pathway. Am J Cancer Res. 10:403–423. 2020.PubMed/NCBI | |
|
Tone AA, McConechy MK, Yang W, Ding J, Yip S, Kong E, Wong KK, Gershenson DM, Mackay H, Shah S, et al: Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas. BMC Cancer. 14:9822014. View Article : Google Scholar : PubMed/NCBI | |
|
Opyrchal M, Gil M, Salisbury JL, Goetz MP, Suman V, Degnim A, McCubrey J, Haddad T, Iankov I, Kurokawa CB, et al: Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells. Oncotarget. 8:91803–91816. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ryu TY, Kim K, Kim SK, Oh JH, Min JK, Jung CR, Son MY, Kim DS and Cho HS: SETDB1 regulates SMAD7 expression for breast cancer metastasis. BMB Rep. 52:139–144. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Gao YQ, Liu M and Zhang H: Expression profiles of Smad1 protein in lung cancer tissues and normal tissues and its effect on lung cancer incidence. J Biol Regul Homeost Agents. 30:165–171. 2016.PubMed/NCBI | |
|
Chae DK, Ban E, Yoo YS, Kim EE, Baik JH and Song EJ: MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer. Mol Carcinog. 56:1992–1998. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun W, Ma Y, Chen P and Wang D: MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-β/Smad2/STAT3/STAT5 pathway. Mol Med Rep. 11:3854–3859. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Lu Y, Sheng B, Ding Y and Cheng X: Catalpol inhibits TGF-β1-induced epithelial-mesenchymal transition in human non-small-cell lung cancer cells through the inactivation of Smad2/3 and NF-κB signaling pathways. J Cell Biochem. Sep 11–2018.(Online ahead of print). | |
|
Wei Y, Li D, Wang D, Qiu T and Liu K: WITHDRAWN: Evaluation of microRNA-203 in bone metastasis of patients with non-small cell lung cancer through TGF-β/SMAD2 expression. Oncol Rep. Sep 21–2017.(Online ahead of print). View Article : Google Scholar | |
|
Zhang JX, Zhai JF, Yang XT and Wang J: MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 20:3793–3801. 2016.PubMed/NCBI | |
|
Chen Y, Xing P, Chen Y, Zou L, Zhang Y, Li F and Lu X: High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer. World J Surg Oncol. 12:3282014. View Article : Google Scholar : PubMed/NCBI | |
|
Qian Z, Zhang QK, Hu Y, Zhang T, Li J, Liu Z, Zheng H, Gao Y, Jia W, Hu A, et al: Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer. Respir Res. 19:2622018. View Article : Google Scholar : PubMed/NCBI | |
|
Ziemke M, Patil T, Nolan K, Tippimanchai D and Malkoski SP: Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer. Lung Cancer. 109:28–35. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen H, Wang JW, Liu LX, Yan JD, Ren SH, Li Y and Lu Z: Expression and significance of transforming growth factor-β receptor type II and DPC4/Smad4 in non-small cell lung cancer. Exp Ther Med. 9:227–231. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
D'Haene N, Le Mercier M, Salmon I, Mekinda Z, Remmelink M and Berghmans T: SMAD4 mutation in small cell transformation of epidermal growth factor receptor mutated lung adenocarcinoma. Oncologist. 24:9–13. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Haeger SM, Thompson JJ, Kalra S, Cleaver TG, Merrick D, Wang XJ and Malkoski SP: Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors. Oncogene. 35:577–586. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng YY, Zhu JJ, Shen D, Qin H, Lei Z, Li W, Liu Z and Huang JA: MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo. Oncotarget. 8:30817–30829. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Takahashi K, Nishikawa S, Miyata R, Noguchi M, Ishikawa H, Yutaka Y, Nakajima D, Hamaji M, Ohsumi A, Menju T, et al: Tranilast inhibits TGF-beta-induced EMT and invasion/metastasis via the suppression of smad4 in lung cancer cell lines. Ann Oncol 29:. (Suppl 8):viii1–viii13. 2018. | |
|
Lee CC, Yang WH, Li CH, Cheng YW, Tsai CH and Kang JJ: Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4. Cancer Lett. 376:211–217. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yanagisawa K, Uchida K, Nagatake M, Masuda A, Sugiyama M, Saito T, Yamaki K, Takahashi T and Osada H: Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers. Oncogene. 19:2305–2311. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Wang J, Zeng X, Li D, Ding M, Guan R, Yuan L, Zhou Q, Guo M, Xiong M, et al: Two-stage study of lung cancer risk modification by a functional variant in the 3′-untranslated region of SMAD5 based on the bone morphogenetic protein pathway. Mol Clin Oncol. 8:38–46. 2018.PubMed/NCBI | |
|
Ngeow J, Yu W, Yehia L, Niazi F, Chen J, Tang X, Heald B, Lei J, Romigh T, Tucker-Kellogg L, et al: Exome sequencing reveals germline SMAD9 mutation that reduces phosphatase and tensin homolog expression and is associated with hamartomatous polyposis and gastrointestinal ganglioneuromas. Gastroenterology. 149:886–889 e5. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Gan H, Song W, Chai D and Wu S: MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5. Scand J Gastroenterol. 53:769–776. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Shi JQ, Wang B, Cao XQ, Wang YX, Cheng X, Jia CL, Wen T, Luo BJ and Liu ZD: Circular RNA_LARP4 inhibits the progression of non-small-cell lung cancer by regulating the expression of SMAD7. Eur Rev Med Pharmacol Sci. 24:1863–1869. 2020.PubMed/NCBI | |
|
Jin L, Zhu C, Wang X, Li C, Cao C, Yuan J and Li S: Urocortin attenuates TGFβ1-induced Snail1 and slug expressions: Inhibitory role of Smad7 in Smad2/3 signaling in breast cancer cells. J Cell Biochem. 116:2494–2503. 2015. View Article : Google Scholar : PubMed/NCBI |
